Eskiizmir, G. Et Al. 2016. Cetuximab alone has a dose-dependent antitumor effect in oral cavity cancer cells: an in vitro study. ENT Updates , vol.6, no.3 , 105-109.

Eskiizmir, G., ÇALIBAŞI KOÇAL, G., Uysal, T., ELLİDOKUZ, H., & BAŞBINAR, Y., (2016). Cetuximab alone has a dose-dependent antitumor effect in oral cavity cancer cells: an in vitro study. ENT Updates , vol.6, no.3, 105-109.

Eskiizmir, Gorkem Et Al. "Cetuximab alone has a dose-dependent antitumor effect in oral cavity cancer cells: an in vitro study," ENT Updates , vol.6, no.3, 105-109, 2016

Eskiizmir, Gorkem Et Al. "Cetuximab alone has a dose-dependent antitumor effect in oral cavity cancer cells: an in vitro study." ENT Updates , vol.6, no.3, pp.105-109, 2016

Eskiizmir, G. Et Al. (2016) . "Cetuximab alone has a dose-dependent antitumor effect in oral cavity cancer cells: an in vitro study." ENT Updates , vol.6, no.3, pp.105-109.

@article{article, author={Gorkem Eskiizmir Et Al. }, title={Cetuximab alone has a dose-dependent antitumor effect in oral cavity cancer cells: an in vitro study}, journal={ENT Updates}, year=2016, pages={105-109} }